Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT06707220 (TURK-HF) for Heart Failure is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
The Türkiye Heart Failure Registry (TURK-HF) 5,000 Real-World Evidence Novel Treatment
Clinical Trial NCT06707220 (TURK-HF) is an observational study for Heart Failure that is recruiting. It started on 8 January 2025 with plans to enroll 5,000 participants. Led by Baskent University, it is expected to complete by 1 December 2027. The latest data from ClinicalTrials.gov was last updated on 3 March 2025.
Brief Summary
A comprehensive understanding of the socio-demographic, clinical, and biological characteristics of patients with heart failure is essential to develop novel strategies for improving outcomes. The identification of the barriers to guideline-directed medical therapy implementation in a real-world setting is critical to decreasing the risk of heart failure hospitalization and mortality. A comprehensive and well-designe...Show More
Official Title
The Türkiye Heart Failure (TURK-HF) Registry
Conditions
Heart FailurePublications
Scientific articles and research papers published about this clinical trial:Other Study IDs
- TURK-HF
- KA23/429
NCT ID Number
Start Date (Actual)
2025-01-08
Last Update Posted
2025-03-03
Completion Date (Estimated)
2027-12
Enrollment (Estimated)
5,000
Study Type
Observational
Status
Recruiting
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
N/A | Heart failure medication Treated with optimal guideline-directed medical therapy |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Heart failure hospitalization | From enrollment to the end of follow-up period at 12 months | |
Cardiovascular mortality | From enrollment to the end of follow-up period at 12 months | |
Composite of heart failure hospitalization and cardiovascular mortality | From enrollment to the end of follow-up period at 12 months |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
All-cause mortality | From enrollment to the end of follow-up period at 12 months |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
Presence of heart failure -
Age <18 years
-
Baskent UniversityStudy Responsible Party
Umut Kocabas, Principal Investigator, Medical Doctor, Baskent University
Study Central Contact
Contact: Umut Kocabaş, +905079974999, [email protected]
1 Study Locations in 1 Countries
Ankara
Baskent University, Ankara, Ankara, 0600, Turkey (Türkiye)
Umut Kocabaş, M.D., Contact, +905079974999, [email protected]
Recruiting